This review highlights the diversity of metabolic pathways involved in PAH, including changes in glycolysis and increased glutaminolysis and FAO that are mediated by several enzyme systems and key transcription factors with HIF-1 α foremost. This evidence concerns the gene SETD2 and pulmonary arterial hypertension.